3Sherman RA, Pechter EA. Maggot therapy: a review of the therapeutic applications of fly larvae in human medicine, especially for treating osteomyelitis[J]. Med Vet Entomol,1988,2(3):225 230.
4Sherman RA, Shapiro CE, Yang RM. Maggot therapy for problematic wounds: uncommon and off-label applications[J]. Adv Skin Wound Care,2007,20(11):602-610.
5Steenvoorde P, Jacobi CE, van Doorn I., et al. Maggot dcbridement therapy of infected ulcers: patient and wound f,fators influencing outcome-a study on 101 patients with 117 wounds[J]. Ann R Coll Surg Engl,2007,89(6):596-602.
7Steenvoorde P, Jacobi CE, Oskam J. Maggot debridement therapy free range or conlained? Anin-vivo study[J].AdvSkin Wound Care,2005,18(8) :430-435.
8Jaklic D, Lapanje A, Zupancic K, et al. Selective antimicrobial activity of maggots against pathogenic bacteria[J]. J Med Microbiol,2008,57(Pt 5):617 625.
3Parnés A,Lagan K M.Larval therapy in wound management:a review[J].Int J Clin Pract,2007,61(3):488-493.
4Dumville J C,Worthy G,Bland J M,et al.Larval therapy for leg ulcers (VenUS Ⅱ):randomised controlled trial[J].BMJ,2009,338:b773.
5Soares M O,Iglesias C P,Bland J M,et al.Cost effectiveness analysis of larval therapy for leg ulcers[J].BMJ,2009,338:b825.
6Ternhag A.Larval therapy for leg ulcers.Compression may be key[J].BMJ,2009,338:b2064.
7Jelnes R.Larval therapy for leg ulcers.Wrong treatment[J].BMJ,2009,338:b2063.
8Grassberger M,Fleischmann W.The biobag-a new device for the application of medicinal maggots[J].Dermatology,2002,204(4):306.
9Whitaker I S,Twine C,Whitaker M J,et al.Larval therapy from antiquity to the present day:mechanisms of action,clinical applications and future potential[J].Postgrad Med J,2007,83(980):409-413.
10Sherman R A.Maggot therapy takes us back to the future of wound care:new and improved maggot therapy for the 21st century[J].Diabetes Sci Technol,2009,3(2):336-344.
1Schinzel A. Catalogue of unbalanced chromosome aberrations in man[M]. 2nd ed. New York: Walter de Gruyter Inc, 200 1.
2Galasso C, Lo-Castro A, Lalli C, et al. Deletion 2q37: an identifiable clinical syndrome with mental retardation and autism[J]. J Child Neural ,2008 ,23(7) :802 - 806.
3Casas KA, Mononen TK, Mikail CN, et al. Chromosome 2q terminal deletion: report of 6 new patients and review of phenotype - breakpoint correlations in 66 individuals [J]. Am J Med Genetics Part A ,2004,130(4) :331 - 339.
4Aldred MA, Sanford ROC, Thomas NS, et al. Molecular analysis of 20 patients with 2q37. 3 monosomy , definition of minimum deletion intervals for key phenotypes [J]. J Med Ggenetics ,2004,41(6) :433 - 439.
5Wilson LC, Leverton K, Luttikhuis MEMO, et al. Brachydactyly and mental retardation: an Albright hereditary osteodystrophy-like syndrome localized to 2q37 [J]. Am J Hum Genet, 1995 ,56(2) :400 - 407.
6Conrad B, Dewald G, Christensen E, et al. Clinical phenotype associated with terminal 2q37 deletion[J]. Clin Genetics, 1995 ,48 (3) : 134 - 139.
7Gorski ]L,Cox BA, Kyine M, et al. Terminal deletion of the long arm of chromosome 2 in a mildly dysmorphic hypotonic infant with karyotype 46, XY ,del (2)( q3 7) [J]. Am J Med Genetics, 1989 ,32(3) :350 - 352.
8Leroy C, Landais E, Briault S, et al. The 2q37-deletion syndrome: an update of the clinical spectrum including overweight, brachydactyly and behavioural features in 14 new patients[J]. Eur J Hum Genetics, 2013,21 (6) : 602 - 612.
9Surana RB,Conen PE. Partial trisomy 4 resulting from a 4 - 18 reciprocal translocation[J]. Ann Genet, 1972,15 (3) : 191-194.
10Cervenka], Djavadi GR, Gorlin RJ. Partial trisomy 4q syndrome: case report and review [J]' Hum Genetics, 1976,34(1):1 -7.
